Quince Therapeutics, Inc.
QNCX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$57 | -$31 | -$52 | -$90 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | -$0 | -$0 | $1 |
| Stock-Based Comp. | $5 | $5 | $17 | $30 |
| Change in WC | -$0 | $2 | -$10 | -$4 |
| Other Non-Cash | $20 | $6 | $1 | $0 |
| Operating Cash Flow | -$32 | -$18 | -$44 | -$63 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | -$2 | $11 | -$59 |
| Inv. Purchases | -$90 | -$114 | -$75 | -$39 |
| Inv. Sales/Matur. | $109 | $111 | $82 | $98 |
| Other Inv. Act. | $2 | -$1 | $0 | $59 |
| Investing Cash Flow | $22 | -$6 | $18 | $59 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$0 | -$0 | $0 |
| Stock Issued | $0 | $0 | $1 | $7 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$5 | $0 | $0 | $0 |
| Financing Cash Flow | -$5 | $0 | $1 | $7 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$15 | -$24 | -$25 | $3 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $21 | $45 | $70 | $67 |
| End Cash | $6 | $21 | $45 | $70 |
| Free Cash Flow | -$32 | -$18 | -$44 | -$63 |